Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified November 2005 by McMaster University.
Recruitment status was: Not yet recruiting

Sponsor:

Information provided by:

McMaster University

ClinicalTrials.gov Identifier:

NCT00280449

First received: January 20, 2006

Last updated: NA

Last verified: November 2005

History: No changes posted

Purpose

This study will examine the effects of having a case manager help PHAs access and use health, social services and practical resources that are helpful to their needs as compared to the usual more PHA self-managed approach of deciding and using services as they see necessary. New and existing users of HIV/AIDS services in Wellington-Dufferin, Waterloo and Grey-Bruce Regions who consent to this study will be randomized to receive their usual self-directed supportive, educational, medical and medical care services when they seek assistance according to their needs or these usual services augmented by case management services. They will be measured before randomization and at 3, 6 and 12 months following service use for their satisfaction with HIV/AIDS services, compliance with HIV/AIDS medication, improvement in quality of life, psychological distress, risk behaviours and expenditures for the use of a range of publicly funded services.

Condition	Intervention	Phase
HIV Infection	Behavioral: strengths-based case managed proactive service model	Phase 1


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment
Official Title:	Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS (PHAs): The Comparative Impact on Quality of Life, Access to and Expenditures for All Health and Social Services

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by McMaster University:

Primary Outcome Measures:

risk behavior, quality of life, health and social service utilization

Secondary Outcome Measures:

depression, satisfaction


Estimated Enrollment:	120
Study Start Date:	March 2006
Estimated Study Completion Date:	February 2007

Eligibility


Ages Eligible for Study:	18 Years to 65 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

HIV-positive individuals
living in the community setting

Exclusion Criteria:

cognitive impairment

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00280449

Contacts


Contact: Robin Weir, PhD	905-5259140	weirr@mcmaster.ca
Contact: Karen Auld	905-5259140 ext 27237	auldka@mcmaster.ca

Locations


Canada, Ontario
McMaster University	Not yet recruiting
Hamilton, Ontario, Canada, L8N 3Z5
Contact: Karen Auld 905-525 9140 ext 27237 auldka@mcmaster.ca
Principal Investigator: Adriana Carvalhal, MD, PhD

Sponsors and Collaborators

Hamilton Health Sciences Corporation

Investigators


Principal Investigator:	Adriana Carvalhal, MD, PhD	McMaster University

More Information


ClinicalTrials.gov Identifier:	NCT00280449 History of Changes
Other Study ID Numbers:	05-357
Study First Received:	January 20, 2006
Last Updated:	January 20, 2006

Keywords provided by McMaster University:


people living with HIV quality of life

Additional relevant MeSH terms:


HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases	Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases

ClinicalTrials.gov processed this record on June 23, 2017

To Top